IXIFI
IXIFI
Approved
DIN Number
02523191
Drug Class
Human
Market Date
Apr 1, 2025
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02523191
AIG Number0144162001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AB02 INFLIXIMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification90:24.16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
INFLIXIMABActive
Strength: 100 MG / VIAL
Monograph: INFLIXIMAB